Hepatic manifestations of non-steroidal inflammatory bowel disease therapy-Reference-Cited by-同舟云学术

Hepatic manifestations of non-steroidal inflammatory bowel disease therapy

Published:2015 Issue:27 Volume:7 Page:2716
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Hirten Robert

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference131 articles.

1. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

2. Abnormal Hepatic Biochemistries in Patients With Inflammatory Bowel Disease

3. Svartz N. Salazyoprin, a new sulfanilamide preparation: A. Therapeutic results in rheumatic polyarthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations in treatment with sulfanilamide preparation. Acta Med Scand 1942;110:557-590.

4. Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor κB activation in mouse colonocytes

5. Influence of Sulphasalazine and Mesalazine on Cellular and Biochemical Oxygen Metabolite Production Effect of in vivo Administration and an in vitro Analysis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Desloratadine via its anti-inflammatory and antioxidative properties ameliorates TNBS-induced experimental colitis in rats;Immunopharmacology and Immunotoxicology;2024-05-30

2. Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis;JGH Open;2022-07-19

3. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders;World Journal of Hepatology;2021-12-27

4. Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity;Antioxidants & Redox Signaling;2021-07-07

5. Hepatobiliary Manifestation of Inflammatory Bowel Disease;The Korean Journal of Gastroenterology;2019